![Liana Patt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Liana Patt
Chief Executive Officer at
FutuRx Ltd.
Profile
Liana Patt currently works at FutuRx Ltd., as Chief Executive Officer from 2022, Lipomedix Pharmaceuticals Ltd., as Director, Ayana Pharma Ltd., as Director, GliXogen Therapeutics Ltd., as Director from 2022, and HighRAD Ltd., as Director.
Dr. Patt also formerly worked at Integra Holdings Ltd., as Chief Executive Officer, Atox Bio Ltd., as Director, and Teva Pharmaceutical Industries Ltd., as Vice President-Global Business Development.
Dr. Patt received her undergraduate degree in 1989 from Tel-Aviv University, doctorate degree from Weizmann Institute of Science, and Masters Business Admin degree from Edinburgh Business School.
Liana Patt active positions
| Companies | Position | Start |
|---|---|---|
Lipomedix Pharmaceuticals Ltd.
 Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products | Director/Board Member | - |
HighRAD Ltd.
 HighRAD Ltd. Packaged SoftwareTechnology Services Operates as an oncology AI imaging platform for clinical applications | Director/Board Member | - |
Glixogen Therapeutics Ltd.
 Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic products | Director/Board Member | 08/06/2022 |
Ayana Pharma Ltd.
 Ayana Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the development of liposomal therapeutics for the treatment of cancer | Director/Board Member | - |
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Chief Executive Officer | 01/05/2022 |
Former positions of Liana Patt
| Companies | Position | End |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | - |
Integra Holdings Ltd.
 Integra Holdings Ltd. MiscellaneousMiscellaneous Operates as a holding company | Chief Executive Officer | - |
Atox Bio Ltd.
 Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Director/Board Member | - |
Training of Liana Patt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
81
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Teva Pharmaceutical Industries Ltd.
 Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Provides novel immune modulators for critically ill patients with severe infections | Health Technology |
Integra Holdings Ltd.
Integra Holdings Ltd. MiscellaneousMiscellaneous Operates as a holding company | Miscellaneous |
Edinburgh Business School
 Edinburgh Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lipomedix Pharmaceuticals Ltd.
Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceutical products | Health Technology |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Finance |
Ayana Pharma Ltd.
Ayana Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the development of liposomal therapeutics for the treatment of cancer | Health Technology |
Glixogen Therapeutics Ltd.
Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic products | Commercial Services |
HighRAD Ltd.
HighRAD Ltd. Packaged SoftwareTechnology Services Operates as an oncology AI imaging platform for clinical applications | Technology Services |
- Stock Market
- Insiders
- Liana Patt
